Atherosclerosis is considered to be a form of chronic inflammation governed by a complex
network of inter-and intra-cellular signaling pathways. The pleiotropic cytokine interferon-γ …

Atherosclerosis is considered to be a chronic inflammatory disease of the arterial wall.
Atherogenesis is accompanied by local production and release of inflammatory mediators …

Atherosclerosis is a chronic inflammatory disease that is characterized by the development
of fibrotic plaques in the arterial wall. The disease exhibits a complex aetiology and its …

Purpose Cardiovascular disease (CVD) is the leading cause of death, globally, and its
prevalence is only expected to rise due to the increasing incidence of co-morbidities such as …

Atherosclerosis is a chronic inflammatory disorder of the vasculature and is the primary
cause of cardiovascular disease (CVD). CVD is currently the world's leading cause of death …

Inflammatory cytokines are well-recognized mediators of atherosclerosis. Depending on the
pathological context, type I interferons (IFNs; IFNα and IFNβ) exert either pro-or anti …

Interferons (IFNs) are key regulators of both innate and adaptive immune responses. The
family of IFN cytokines can be divided into 3 main subtypes of which type I and type II IFNs …

Atherosclerosis is a chronic inflammatory disease of the vasculature with lesions developing
in the arterial wall, frequently in the coronary and carotid arteries. The interaction between …

Research during the last two decades established atheromatous lesions as active sites of
inflammation and immune responses, contrasting to the traditional view of atherosclerosis as …

The contribution of dyslipidemia and inflammation in atherosclerosis is well established.
Along with effective lipid-lowering treatments, the recent success of clinical trials with anti …